GE, Sealed Air to Produce Film for Biopharmaceuticals

GE Healthcare’s Life Sciences unit and Sealed Air Corporation announced Tuesday that the two companies formed an alliance to develop primary films for the biopharmaceuticals industry.

“GE and Sealed Air share a vision of the importance of robust, high quality films in the efficient manufacture of life saving medicines such as monoclonal antibodies, vaccines, and next generation biotheraputics,” said Morgan Norris, general manager of upstream products at GE Healthcare’s Life Sciences unit, in a statement. “Through this partnership we are confident that we will deliver the next level of purposefully constructed and manufactured films for bioprocessing applications, enabling improved performance, supply chain control, and material/supplier transparency that the market demands for single-use suppliers.”

The latest agreement is a further development in GE and Sealed Air’s long-term relationship. The companies developed a new film for use across Ge’s full single-use portfolio.